HSHelen B. Gomez Slagle

Helen B. Gomez Slagle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Helen B. Gomez Slagle has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neonatal Outcomes in Transposition of the Great Arteries by Mode and Timing of Delivery

    by Helen B. Gomez Slagle, Maria Andrikopoulou, Russell S Miller, Yijia Zhang, Angelica M. Vasquez, Lynn L. Simpson

    We aimed to assess neonatal outcomes by mode of delivery and to evaluate the value of achieving daytime delivery among neonates undergoing a planned induction of labor (IOL). This was a retrospective study of pregnancies with prenatally diagnosed d-TGA with an IVS receiving care at a single tertiary care referral center from 2020 to 2023. Inclusion required prenatal diagnosis of d-TGA with an IVS and surgical care at the referral center. The primary outcome was a composite of neonatal outcomes, including preoperative inhaled nitric oxide use, inotrope use, preoperative mortality, reoperation, readmission, delayed sternal closure, diaphragmatic paralysis, and postoperative mortality. Secondary surgical outcomes and composite neurological morbidity, including hypoxic-ischemic encephalopathy, seizures, intraventricular hemorrhage, or stroke, were collected. Pearson's chi-square or Fisher's exact test was performed as appropriate. We identified 90 cases of prenatally diagnosed d-TGA, of which 68 (76%) underwent timed IOL and 46 (68%) achieved vaginal delivery. The primary outcome occurred in 16 neonates (89%) who were delivered by cesarean and 47 neonates (78%) who underwent a planned timed IOL (p = 0.26). Among individuals undergoing IOL, the primary outcome occurred in 29 neonates (73%) who delivered during the daytime and 18 (90%) who delivered after-hours (p = 0.19). We found that in cases of prenatally diagnosed d-TGA with an IVS, IOL is feasible. Neonates with d-TGA with an IVS had similar surgical outcomes when induced and delivered at this single tertiary care center, regardless of delivery time.

  • Associations Between Fetal Genetic Abnormalities, Lesion Size, and Postnatal Outcomes Among Pregnancies Complicated by Fetal Omphalocele

    by Helen B. Gomez Slagle, Russell S. Miller, Vincent P. Duron, Ronald J. Wapner, Lynn L. Simpson, Noelle Breslin

    Objectives: This study aimed to determine if omphalocele ratios can function as predictors of genetic abnormalities and to assess whether genetic anomalies influence postnatal surgical closure in pregnancies complicated by fetal omphalocele. Methods: This was a retrospective study of pregnancies complicated by fetal omphalocele. Omphalocele size, ratios, and presence of extracorporeal liver were evaluated as predictors of abnormal genetic testing results. Surgical outcomes of subjects with identified genetic abnormalities were compared to those without genetic anomalies. Receiver operating curve analyses were performed to predict abnormal genetic testing. Results: Hundred and thirty‐nine fetal omphalocele cases were identified during the study period, with 56 cases included in this analysis. Abnormal genetic results were detected in 9 cases (16.1%). Omphalocele size cut‐offs and ratios were poor predictors of genetic abnormality. Patients with genetic findings were more likely to present with smaller omphaloceles. Primary closure occurred in 89% of neonates with a genetic abnormality versus 42.5% of neonates without a genetic anomaly ( P = .02). Conclusion: While pregnancies with genetic abnormalities were associated with smaller lesions and higher rates of primary surgical closure, no lesion measurement performed well as a predictor of genetic abnormality. Our findings support offering genetic testing in all cases of fetal omphalocele, regardless of size.

  • A Validated Calculator to Estimate Risk of Chorioamnionitis in Laboring and Induced Patients at Term

    by Helen B. Gomez Slagle, Richard J Caplan, Tetsuya Kawakita, Anthony C. Sciscione, Matthew K. Hoffman

    Chorioamnionitis is associated with neonatal morbidity and infection-related mortality, but our ability to predict intrapartum infection is limited. We sought to derive and validate a prediction model for chorioamnionitis among patients presenting to labor and delivery at term.This was a planned secondary analysis of a large cohort study from 2014 through 2018 at an academic tertiary care center. To derive a prediction model for chorioamnionitis, we limited our analysis to full-term (≥37 weeks) patients with a singleton gestation undergoing labor induction and presenting in labor. Both nulliparous and multiparous patients were included. Patients with a planned cesarean delivery, fever on admission, or missing data were excluded. The model was derived using multivariable logistic regression. Refinement of the prediction model with internal calibration was performed. External validation was performed utilizing a publicly available database (Consortium on Safe Labor) and applying the same inclusion and exclusion criteria. The discriminative power of each model was assessed using a bootstrap, bias-corrected area under the curve.The chorioamnionitis rates in the derivation and external validation groups were 5% (1,005/19,966) and 5.8% (n = 3,005/52,171), respectively. In multivariable modeling, maternal age, nulliparity, gestational age, smoking status, group B Streptococcus colonization, hours ruptured, number of cervical exams, length of labor, epidural use, internal monitoring, and meconium were significantly associated with infection. A calculator was created and externally validated with an area under the curve of 0.82 (95% confidence interval, 0.81–0.82). External validity was further confirmed with a calibration intercept of 0.81.This is the first infection calculator created and validated for the prediction of developing chorioamnionitis in patients undergoing induction of labor at term. This calculator can be used to augment patient counseling and guide intrapartum infection surveillance in laboring patients.

  • Buccal versus Vaginal Misoprostol Combined with a Foley Catheter among Individuals with Obesity Undergoing Induction

    by Helen B. Gomez Slagle, Tetsuya Kawakita, Matthew K. Hoffman, Anthony C. Sciscione, Marwan Ma'AYeh

    Objective Combining pharmacologic agents with mechanical ripening achieves the shortest labor duration, yet there is no clear evidence on route of drug administration in obese individuals. The use of buccal misoprostol has shown greater patient acceptance but remains understudied. Our objective was to evaluate the difference in time to delivery of buccal compared with vaginal misoprostol in combination with a Foley catheter (FC) for induction of labor (IOL) in the obese population. Study Design This was a secondary analysis of a randomized controlled trial comparing identical dosages (25 μg) of buccal and vaginal misoprostol in combination with a FC. The parent trial was an institutional review board-approved, randomized clinical trial conducted from June 2019 through January 2020. Labor management was standardized among participants. Women undergoing IOL at ≥37 weeks with a singleton gestation and cervical dilation ≤2 cm were included. Body mass index (BMI, kg/m2) was stratified. The primary outcome was time to delivery. Results A total of 215 participants were included. Demographic characteristics were similar between the three groups. Vaginal drug administration achieved a faster median time to delivery than the buccal route among patients with a body mass index greater than or equal to 30 kg/m2 (vaginal misoprostol–FC: 21.3 hours vs. buccal misoprostol–FC: 25.2 hours, p = 0.006). There was no difference in the cesarean delivery rate between the two groups. Furthermore, patients with a BMI greater than or equal to 30 kg/m2 receiving vaginal misoprostol delivered 1.2 times faster than women who received buccal misoprostol after censoring for cesarean delivery and adjusting for parity (hazard ratio: 1.2, 95% confidence interval: 1.1–1.7). There were no significant differences in maternal and neonatal outcomes. Conclusion We found that vaginal misoprostol was superior to buccal misoprostol when combined with a FC among individuals with a BMI greater than or equal to 30 kg/m2. Vaginal misoprostol should be the preferred route of drug administration for term IOL in this population. Key Points


  • Combination Foley Catheter–Oxytocin versus Oxytocin Alone following Preterm Premature Rupture of Membranes

    by Helen B. Gomez Slagle, Matthew K. Hoffman, Anthony C. Sciscione, Marwan Ma'AYeh

    Objective The benefit of mechanical ripening agents following preterm premature rupture of membranes (PPROM) has not been established. We sought to compare the time to delivery in women who received transcervical Foley catheter plus oxytocin infusion versus oxytocin infusion alone in patients with unfavorable cervices and PPROM. Study Design This is a retrospective cohort study of patients presenting with PPROM of a live, singleton gestation between 240/7 and 366/7 weeks' gestation from January 2005 to October 2018 at a single, tertiary care institution. Patients with an unfavorable cervical examination (≤2-cm dilation), no contraindication to labor and undergoing labor induction were analyzed. Time to delivery was analyzed using multivariable linear regression adjusting for cervical dilation at induction and nulliparity. Bivariate and multivariate analyses were used where appropriate. Results A total of 260 participants were included: 109 who received a Foley catheter and oxytocin (Foley/oxytocin) and 151 who had oxytocin alone. Demographic characteristics were similar between the two groups. Unadjusted time to delivery was significantly shorter in the oxytocin only group (Foley/oxytocin: 20.35 hours vs. oxytocin alone: 14.7 hours, p < 0.001). No differences in length of labor were detected after adjusting for cervical dilation at induction and nulliparity (p = 0.5). The unadjusted rate of cesarean delivery was higher in the combination Foley/oxytocin group (Foley/oxytocin: 16.5% vs. oxytocin alone: 7.3%, p = 0.03), but no differences were found in the adjusted analysis (p = 0.06). There were no differences in clinical chorioamnionitis rates between the two groups (Foley/oxytocin: 8.3% vs. oxytocin alone: 9.3%, p = 0.83). Furthermore, no significant differences were found in maternal and neonatal outcomes between the two groups. Conclusion In patients with PROM, the use of a transcervical Foley catheter in addition to oxytocin is not associated with a shorter time to delivery compared with oxytocin alone. Key Points


  • Open Access

    Validation of a novel mobile phone application for type 2 diabetes screening following gestational diabetes mellitus

    by Helen B. Gomez Slagle, Matthew K. Hoffman, Richard Caplan, Philip Shlossman, Anthony C. Sciscione

    Validation of a novel mobile phone application for type 2 diabetes screening following gestational diabetes mellitus Helen B. Gomez Slagle, Matthew K. Hoffman, Richard Caplan, Philip Shlossman, Anthony C. Sciscione


  • Early vs expectant artificial rupture of membranes following Foley catheter ripening: a randomized controlled trial

    by Helen B. Gomez Slagle, Yaneve N. Fonge, Richard Caplan, Courtney K. Pfeuti, Anthony C. Sciscione, Matthew K. Hoffman


  • Incremental risk of clinical chorioamnionitis associated with cervical examination

    by Helen B. Gomez Slagle, Matthew K. Hoffman, Yaneve N. Fonge, Richard Caplan, Anthony C. Sciscione


  • Understanding Food Security as a Social Determinant of Diabetes-Related Health during Pregnancy

    by Helen Gomez, Julia D. DiTosto, Charlotte M. Niznik, Lynn M. Yee

    Gestational and pregestational diabetes during pregnancy are substantial and growing public health issues. Low-income individuals and individuals who identify as racial and ethnic minorities are disproportionately affected. Food security, which is defined as the degree to which individuals have capacity to access and obtain food, is at the center of nutritional resources and decisions for individuals with diabetes. While increasingly recognized as an important mediator of health disparities in the United States, food insecurity is understudied during pregnancy and specifically among pregnant individuals with diabetes, for whom the impact of food-related resources may be even greater. Previous research has suggested that food insecurity is associated with type 2 diabetes mellitus diagnoses and disease exacerbation in the general adult population. An emerging body of research has suggested that food insecurity during pregnancy is associated with gestational diabetes mellitus diagnoses and adverse diabetes-related outcomes. Additionally, food insecurity during pregnancy may be associated with adverse maternal and neonatal outcomes. Future research and clinical work should aim to further examine these relationships and subsequently develop evidence-based interventions to improve diabetes-related outcomes among pregnant individuals with food insecurity. The purpose of this article is to offer a working definition of food security, briefly review issues of food insecurity and diabetes, summarize research on food insecurity and diabetes-related pregnancy health, and discuss clinical recommendations and areas for future investigation. Key Points


  • Buccal vs vaginal misoprostol combined with Foley catheter for cervical ripening at term (the BEGIN trial): a randomized controlled trial

    by Helen B. Gomez, Matthew K. Hoffman, Richard Caplan, Kelly Ruhstaller, Matthew H.H. Young, Anthony C. Sciscione